Quantcast
Last updated on April 21, 2014 at 8:43 EDT

Latest Amines Stories

2013-10-21 23:24:40

MarketResearchReports.Biz announces addition of new report “Global Testosterone Market 2012 - 2016” to its database. Visit: http://www.marketresearchreports.biz/analysis-details/global-testosterone-market-2012-2016 Albany, NY (PRWEB) October 21, 2013 Global Testosterone Market 2012 - 2016 Global Testosterone market to grow at a CAGR of 26.26 percent over the period 2012-2016. One of the key factors contributing to this market growth is the increasing aging population across the globe....

2013-10-21 10:09:54

The investigational drug AZD9291, a third-generation EGFR inhibitor, showed promise in preclinical studies and provides hope for patients with advanced lung cancers that have become resistant to existing EGFR inhibitors, according to results presented here at the AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics, held Oct. 19-23. Mutations in the growth factor gene EGFR are present in about 10 to 15 percent of patients with the most common form of lung...

2013-10-21 04:20:56

-- Findings Suggest New Class of Anti-Cancer Agents with Novel Mechanism for Tumor Cell Killing -- SEATTLE, Oct. 21, 2013 /PRNewswire/ -- Cell Therapeutics, Inc. (CTI) (NASDAQ and MTA: CTIC) today announced the presentation of findings from a preclinical study of PIXUVRI(®) (pixantrone) that suggest its mechanism of inducing tumor cell death is novel and distinct from that of anthracyclines such as doxorubicin. PIXUVRI is a first-in-class aza-anthracenedione with unique structural...

2013-10-16 23:23:56

Reportbuyer.com just published a new market research report: PharmaPoint: Non-Small Cell Lung Cancer - China Drug Forecast and Market Analysis to 2022. London (PRWEB) October 16, 2013 PharmaPoint: Non-Small Cell Lung Cancer - China Drug Forecast and Market Analysis to 2022 Summary Non-Small Cell Lung Cancer (NSCLC) is the most common lung cancer, and the second-most common cancer in men and women. Historically, the treatment paradigm has centered around chemotherapy. However, the launch...

2013-10-16 04:21:51

BARCELONA, Spain, October 16, 2013 /PRNewswire/ -- - The results of the study, in patients with acute postoperative moderate to severe pain, show that E-58425 demonstrated superior efficacy and safety over both placebo and a standard of care - E-58425 is a novel, first-in-class, patented, co-crystal product entity - The positive phase II data confirm the Product Concept of E-58425: Clinically relevant and robust pain...

Opioids In The Brain Ease Social Pain
2013-10-11 04:48:35

Brett Smith for redOrbit.com - Your Universe Online While previous research has shown that our brains release pain-killing opioids when the body experiences physical harm, a new study in the journal Molecular Psychiatry has revealed that this system is also activated by social pain. The study researchers also discovered that those who score high on a personality attribute called resilience, or the capacity to cope with environmental change, showed the highest level of natural painkiller...

2013-10-10 12:28:11

SEATTLE, Oct. 10, 2013 /PRNewswire-USNewswire/ -- Opiate overdoses, doctor-shopping by patients seeking controlled substances and opiate misuse are routine enough features of emergency department patient populations that emergency physicians have developed innovative solutions to address these medical and social problems, which are detailed in studies being presented next week in Seattle at the annual meeting of the American College of Emergency Physicians (ACEP13-Scientific...

2013-10-01 08:30:36

Relmada Therapeutics Inc. Announces the Final Closing of a Series A Financing Raising the Maximum Amount of $8 Million Including the Over-Allotment. NEW YORK, Oct. 1, 2013 /PRNewswire/ -- Relmada Therapeutics Inc., a clinical-stage company developing novel therapies for the treatment of chronic pain, today announced the final closing of a Series A financing raising $8 million in gross proceeds. The offer was oversubscribed and Laidlaw & Company (UK) Ltd. acted as the exclusive...

2013-09-30 04:22:27

ANTWERP, Belgium, September 30, 2013 /PRNewswire/ -- Multiplicom NV, a specialist in the development, production and commercialization of innovative molecular genetic tests based on massively parallel sequencing (MPS), today announces that it is launching three new somatic mutation detection kits which will enable users to implement personalized cancer treatment at an unprecedented level. The new kits enable PCR amplification of genes known to be frequently mutated in...

2013-09-26 13:46:13

A team of researchers led by Michel De Waard, Inserm Research Director at the Grenoble Institute of Neurosciences  (Inserm, University Joseph Fourier, CNRS), has discovered that an African medicinal plant produces large quantities of molecules with analgesic properties. Even more surprising, analysis show that the molecule is identical to Tramadol, a wholly synthetic medication that is used world-wide as a painkiller. According to the research team, this is the first time ever that a...